Using QGenome To Determine Eligibility For Anastrazole – Guidance For Primary Care
The Medicines and Healthcare products Regulatory Agency have recently licensed Anastrazole as a preventive option for women at moderate or high risk of breast cancer due to their family history.
Anastrozole: Thousands to be offered drug to prevent breast cancer in England
https://www.bbc.co.uk/news/health-67337081
Tens of thousands of women set to benefit from ‘repurposed’ NHS drug to prevent breast cancer
Women are therefore being advised to contact their GP who can refer them to a specialist for a full risk assessment taking into account family history.
As a result, General Practitioners will need to manage the increased demand from patients for a formal breast cancer risk assessment whilst dealing with the multitude of other conditions they see in their day-to-day clinical practice.
Primary care clinicians need quick readily-accessible guidance which is where QGenome can help.
QGenome is a clinical decision support tool, freely available on iOS, Android or via a Web App. The tool provides dedicated Breast Cancer decision workflows for the following areas:
Referral guidance
Provides a simple brief framework of questions relating to the patient's personal and family history to help users decide whether a patient requires onward referral to tertiary genetics services or whether the patient can be managed within primary or secondary care.
Risk assessment
Used to generate a risk assessment based on personal and family history information that has been entered by the user. The risk assessment assists in determining the patient’s risk level, what risk-reducing options are available and where the patient could be referred for further management.
Genomic testing
Used to help determine a patient's eligibility for genomic testing. Encompasses inherited/rare disease and cancer genomic testing criteria aligned with the NHSE national genomic test directory and provides quick links to key documents, for example genomic test request and consent forms.
Determining Eligibility for Anastrazole
QGenome can support your breast cancer family history consultations in clinic and ensure women who are eligible for Anastrazole can access it in a timely way. We have put together the following guide to help get you started:
Quick Start Guide
QGenome - A quick start guide... — QGenome
Further Information
Website
www.qgenome.co.uk
Web App
https://app.qgenome.co.uk
iOS
https://apps.apple.com/gb/app/quest-genomics/id999802455
Android
https://play.google.com/store/apps/details?id=com.ubqo.cancergenetics